(Q33451335)

English

The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

0 references

Bacillus anthracis

1 reference

based on heuristic

inferred from title

object named as

Herman F Staats

5

0 references

author name string

Afton L McGowen

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Laura P Hale

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Christopher P Shelburne

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Soman N Abraham

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

14 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3544-3552

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Anaphylaxis following quadrivalent human papillomavirus vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Mast cell activators: a new class of highly effective vaccine adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

A sheep in wolf's clothes: can neutrophils direct the immune response?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Th17 cells: effector T cells with inflammatory properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

How do adjuvants work? Important considerations for new generation adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

The perfect mix: recent progress in adjuvant research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Rapidly changing perspectives about mast cells at mucosal surfaces

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Direct injection of plasmid DNA into the skin induces dermatitis by activation of monocytes through toll-like receptor 9.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Suppressive oligodeoxynucleotides inhibit CpG-induced inflammation of the mouse lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Involvement of connective tissue-type mast cells in Th1 immune responses via Stat4 expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

European union regulatory developments for new vaccine adjuvants and delivery systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Needle-free skin patch vaccination method for anthrax

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Recent advances in the discovery and delivery of vaccine adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Design and selection of vaccine adjuvants: animal models and human trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Passive transfer of protection against Bacillus anthracis infection in a murine model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

The neutrophil as a cellular source of chemokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Effect of cholera toxin on vaccine-induced immunity and infection in murine schistosomiasis mansoni

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

21 June 2018

Neutrophils efficiently cross-prime naive T cells in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

Antibody responses after dose-sparing intradermal influenza vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

CpG motif acts as a 'danger signal' and provides a T helper type 1-biased microenvironment for DNA vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

Cholera toxin prevents Th1-mediated autoimmune disease by inducing immune deviation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

Skin reactivity to vasomotor agents in non-eosinophilic and eosinophilic non-allergic rhinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

Sensitivity of human scalp skin to pruritic stimuli investigated by intradermal microdialysis in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

Mast cells and macrophages in normal C57/BL/6 mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

31 October 2018

An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743390

10 December 2018

Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

https://pubmed.ncbi.nlm.nih.gov/19464533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Capric acid and hydroxypropylmethylcellulose increase the immunogenicity of nasally administered peptide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Serum antibody responses after intradermal vaccination against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Dose sparing with intradermal injection of influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Intradermal influenza vaccination--can less be more?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Histopathological studies on the local reactions induced by complete Freund's adjuvant (CFA), bacterial lipopolysaccharide (LPS), and synthetic lipopeptide (P3C) conjugates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Dermal testing of vaccines for children at high risk of allergies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Critical protective role of mast cells in a model of acute septic peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Microbial antigen triggers rapid mobilization of TNF-alpha to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Presence of neutrophil-bearing antigen in lymphoid organs of immune mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Hyper-releasability of mast cells in family members of infants with sudden infant death syndrome and apparent life-threatening events

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Histologic studies of human skin test responses to ragweed, compound 48-80, and histamine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.069

7 January 2021

Vaccine adverse events: separating myth from reality

1 reference

https://pubmed.ncbi.nlm.nih.gov/19464533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19464533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4

1 reference

https://pubmed.ncbi.nlm.nih.gov/19464533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/19464533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2009.03.069

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33451335&oldid=1976052592"